Today, the Vice Chairman & CTO of Opko Health (OPK), Jane Ph Hsiao, bought shares of OPK for $296.1K.
In addition to Jane Ph Hsiao, 9 other OPK executives reported Buy trades in the last month. This is Hsiao’s first transaction since reporting a Buy transaction on TRXC back in March 2018
See today’s analyst top recommended stocks >>
Based on Opko Health’s latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $250 million and GAAP net loss of $27.66 million. In comparison, last year the company earned revenue of $194 million and had a GAAP net loss of $214 million. Currently, Opko Health has an average volume of 33.41M.
Starting in August 2018, OPK received 6 Buy ratings in a row.
The insider sentiment on Opko Health has been positive according to 103 insider trades in the past three months. This sentiment is slightly higher than the average sentiment of company insiders in this sector.
Jane Ph Hsiao’s trades have generated a 12.5% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
OPKO Health, Inc. engages in the provision of healthcare services. It operates through the Diagnostics and Pharmaceuticals segments. The Diagnostics segment comprises clinical laboratory operations which acquired through the Bio-Reference and point-of-care operations.
